Jove
Visualize
联系我们

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

208
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
208
Depression: Overview01:18

Depression: Overview

331
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
331
Long-term Depression01:03

Long-term Depression

2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

741
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
741
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策
  1. 首页
  2. 在接受fingolimod或cladribine的rrms患者中抑郁症,焦虑症和msqol-54结果:一个横截面比较研究
  1. 首页
  2. 在接受fingolimod或cladribine的rrms患者中抑郁症,焦虑症和msqol-54结果:一个横截面比较研究

相关实验视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.1K

在接受fingolimod或cladribine的RRMS患者中抑郁症,焦虑症和MSQOL-54结果:一个横截面比较研究

Müttalip Özbek1, Adalet Arıkanoğlu2, Mehmet Ufuk Aluçlu2

  • 1Kiziltepe State Hospital, Department of Neurology, Mardin 47400, Turkey.

Medicina (Kaunas, Lithuania)
|August 28, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

与克拉迪宾相比,芬戈利莫德可以改善精神健康并减少复发性复发性多发性硬化症患者的疲劳,尽管这两种治疗方法对抑郁和焦虑有类似的影响. 损伤负荷也会影响生活质量.

关键词:
美国在MSQOL-54中焦虑克拉德里宾抑郁症芬戈利莫德多发性硬化症生活质量

更多相关视频

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.8K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

相关实验视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.8K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

科学领域:

  • 神经学
  • 免疫学
  • 精神病学

背景情况:

  • 多发性硬化 (MS) 是一种慢性,免疫媒介的神经疾病,影响年轻人.
  • 在MS中,抑郁症和焦虑症等精神疾病是常见的,显著降低了生活质量 (QoL).
  • 改变疾病的疗法对治疗多发性硬化症至关重要, 但它们对心理健康的影响需要进一步研究.

研究的目的:

  • 在复发性复发性多发性硬化症 (RRMS) 患者中比较口服DMTfingolimod和cladribine对心理健康和QoL的影响.
  • 评估RRMS患者的抑郁,焦虑和与健康相关的生活质量 (HRQoL) 水平.
  • 在RRMS中探索心理健康结果,HRQoL和临床/放射性参数之间的关联.

主要方法:

  • 80名RRMS患者 (年龄在18至50岁之间,EDSS≤3.0) 被分为两组:40人接受了fingolimod治疗,40人接受了cladribine治疗.
  • 使用汉密尔顿抑郁评分表 (HDRS) 和汉密尔顿焦虑评分表 (HARS) 测量抑郁和焦虑.
  • 使用多发性硬化症QOL-54 (MSQOL-54) 仪器评估生活质量;还收集了临床数据 (损伤负担,EDSS,年龄,疾病持续时间).

主要成果:

  • 在fingolimod和cladribine组之间没有发现HDRS和HARS得分的显著差异.
  • 与克拉迪宾相比,芬戈利莫德治疗在能量/ 疲劳和综合心理健康 (CMH) 分域的得分显著更高.
  • 总病变负荷和QoL得分之间观察到负相关性,表明较高的病变负荷与较差的QoL有关.
  • 结论:

    • 芬戈利莫德和克拉迪宾在治疗RRMS患者的抑郁和焦虑症状方面表现出相似的疗效.
    • 芬戈利莫德可能有助于改善RRMS患者的心理健康结果和减轻疲劳.
    • 病变负担,年龄和EDSS得分等临床因素可以独立地影响患者的QOL,无论使用DMT.